Loading

Johnson & Johnson

June 17, 2025
Company Presentation
Oncology
153B
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more at https://www.jnj.com/
Johnson & Johnson
Company HQ City: New Brunswick
Company HQ State: NJ
Company HQ Country: United States
Year Founded: 1886
Lead Product in Development: CARVYKTI® DARZALEX® ERLEADA® IMBRUVICA® STELARA® TREMFYA® XARELTO®

CEO

Joaquin Duato

Development Phase of Lead Product

Multiple Products in Market

Exchange

NYSE

Ticker

JNJ

When you expect your next catalyst update?

n/a

Website

https://jnjinnovation.com/
Primary Speaker
Lesley Stolz
Lesley Stolz, PhD
Head West North America External Scientific Innovation
Johnson & Johnson
Back to Session List

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS